Creative Planning’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Creative Planning’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75	Closed	–	–	4596
2017 Q2	$0	Sell	75 -975	-93%	-$1.12K	﹤0.01%	5089
2017 Q1	$1K	Buy	1,050 +1,000	+2,000%	+$1.09K	﹤0.01%	4603
2016 Q4	$0	Hold	50	–	–	﹤0.01%	5097
2016 Q3	$0	Hold	50	–	–	﹤0.01%	4942
2016 Q2	$0	Hold	50	–	–	﹤0.01%	4750
2016 Q1	$0	Sell	50 -56	-53%	-$75	﹤0.01%	4817
2015 Q4	$0	Buy	106 +56	+112%	+$75	﹤0.01%	4852
2015 Q3	$0	Buy	+50	New	+$96	﹤0.01%	4456
2015 Q2	–	Sell	-50	Closed	–	–	4093
2015 Q1	$0	Hold	50	–	–	﹤0.01%	4661
2014 Q4	$0	Buy	+50	New	+$169	﹤0.01%	4603

Other funds holding CELGZ

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

MSTVIM

Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Creative Planning's CELGZ Position: Q3 2017 in Review

Creative Planning sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2017, closing a stake of 75 shares.

Creative Planning first reported a position in CELGZ in Q4 2014 and held it in 10 quarters. The position peaked at $1K in Q1 2017. 19 funds tracked by Wall St. Rank hold CELGZ as of Q3 2017.

Creative Planning reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 75 Celgene Corporation Contingent Value Rights shares in Q3 2017.
Creative Planning first reported a position in Celgene Corporation Contingent Value Rights in Q4 2014 and held it in 10 quarters.
Creative Planning's Celgene Corporation Contingent Value Rights position peaked at $1K in Q1 2017.
19 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.